The problem of hemorrhagic syndrome in its treatment with vitamin K antagonists (a review of literature)
Vitamin K antagonists (warfarin, syncumar, phenylin, etc.) are commonly used to treat and prevent thrombotic diseases. The risk for varying degrees of hemorrhagic syndrome (intracranial hemorrhage in particular) is the most important problem in the use of drugs from this group. The rapid neutralizat...
Main Authors: | S A Vasil'ev, V L Vinogradov, É G Gemdzhian |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2012-07-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31107 |
Similar Items
-
The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study
by: Sofia Dahlberg, et al.
Published: (2021-01-01) -
Adherence to treatment and anticoagulation control in vitamin K antagonists-treated patients: an administrative databases analysis in a large Italian population
by: Luca Degli Esposti, et al.
Published: (2011-06-01) -
Emergency reversal of vitamin-K antagonists related over-anticoagulation: case report and brief overview on the role of Prothrombin Complex Concentrate
by: Stefania Angela Di Fusco, et al.
Published: (2013-12-01) -
Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland
by: Micha T. Maeder, et al.
Published: (2017-10-01) -
Development and validation of a mobile application based on a machine learning model to aid in predicting dosage of vitamin K antagonists among Indian patients post mechanical heart valve replacement
by: M. Amruthlal, et al.
Published: (2022-11-01)